Type III CRISPR-based RNA editing for programmable control of SARS-CoV-2 and human coronaviruses

Gene-editing technologies, including the widespread usage of CRISPR endonucleases, have the potential for clinical treatments of various human diseases. Due to the rapid mutations of SARS-CoV-2, specific and effective prevention and treatment by CRISPR toolkits for coronavirus disease 2019 (COVID-19...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Ping, Shen, Guanwang, Guo, Kai, Qin, Shugang, Pu, Qinqin, Wang, Zhihan, Gao, Pan, Xia, Zhenwei, Khan, Nadeem, Jiang, Jianxin, Xia, Qingyou, Wu, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Methods Online
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9071467/
https://www.ncbi.nlm.nih.gov/pubmed/35166837
http://dx.doi.org/10.1093/nar/gkac016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9071467/
https://www.ncbi.nlm.nih.gov/pubmed/35166837
http://dx.doi.org/10.1093/nar/gkac016

Ejemplares similares